Evidence map›Paper›PMID 9774665›Full record

ArticleMolecular and cellular biology1998

Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid.

E R Hofmann, M Boyanapalli, D J Lindner, X Weihua, B A Hassel, R Jagus, P L Gutierrez, D V Kalvakolanu, E R Hofman

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Regulation of snoRNAs in cancer: close encounters with interferon.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2013
    Review
  15. Article
  16. Article
  17. Article
  18. GRIM-19 Expression and Function in Human Gliomas.Journal of Korean Neurosurgical Society · 2010
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Hofman ER [corrected to Hofmann ER]
5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

E R HofmannDepartment of Microbiology & Immunology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, USA.
M Boyanapalli
D J Lindner
X Weihua
B A Hassel
R Jagus
P L Gutierrez
D V Kalvakolanu
E R Hofman
U-M Rogel Cancer CenterUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferons (IFNs) and retinoids are potent biological response modifiers. By using JAK-STAT pathways, IFNs regulate the expression of genes involved in antiviral, antitumor, and immunomodulatory actions. Retinoids exert their cell growth-regulatory effects via nuclear receptors, which also function as transcription factors. Although these ligands act through distinct mechanisms, several studies have shown that the combination of IFNs and retinoids synergistically inhibits cell growth. We have previously reported that IFN-beta-all-trans-retinoic acid (RA) combination is a more potent growth suppressor of human tumor xenografts in vivo than either agent alone. Furthermore, the IFN-RA combination causes cell death in several tumor cell lines in vitro. However, the molecular basis for these growth-suppressive actions is unknown. It has been suggested that certain gene products, which mediate the antiviral actions of IFNs, are also responsible for the antitumor actions of the IFN-RA combination. However, we did not find a correlation between their activities and cell death. Therefore, we have used an antisense knockout approach to directly identify the gene products that mediate cell death and have isolated several genes associated with retinoid-IFN-induced mortality (GRIM). In this investigation, we characterized one of the GRIM cDNAs, GRIM-12. Sequence analysis suggests that the GRIM-12 product is identical to human thioredoxin reductase (TR). TR is posttranscriptionally induced by the IFN-RA combination in human breast carcinoma cells. Overexpression of GRIM-12 causes a small amount of cell death and further enhances the susceptibility of cells to IFN-RA-induced death. Dominant negative inhibitors directed against TR inhibit its cell death-inducing functions. Interference with TR enzymatic activity led to growth promotion in the presence of the IFN-RA combination. Thus, these studies identify a novel function for TR in cell growth regulation.

Indexed as

Amino Acid SequenceApoptosisBreast NeoplasmsCell CycleCell DivisionFlow CytometryGene Expression Regulation, NeoplasticHumansInterferonsMolecular Sequence DataNeoplasm ProteinsOligonucleotides, AntisenseSequence AnalysisThioredoxin-Disulfide ReductaseTretinoinTumor Cells, CulturedInterferonsNeoplasm ProteinsOligonucleotides, AntisenseThioredoxin-Disulfide ReductaseTretinoin

Identifiers

PMID9774665
PMCPMC109235
OpenAlexW2126408170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.